Limba
|
Tulmimetostat (CPI-0209) is an orally bioavailable and selective inhibitor of EZH2that has therapeutic potential for androgen receptor-dependent prostate cancer.
Price | 1.476,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Tulmimetostat (CPI-0209) is an orally bioavailable and selective inhibitor of EZH2that has therapeutic potential for androgen receptor-dependent prostate cancer. |